Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-12-255656
Filing Date
2012-05-31
Accepted
2012-05-31 17:11:21
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d361172ds3.htm S-3 420110
2 AMENDMENT NO. 1 TO AT MARKET ISSUANCE SALES AGREEMENT DATED AS OF MAY 31, 2012 d361172dex12.htm EX-1.2 8248
3 FORM OF SENIOR INDENTURE d361172dex413.htm EX-4.13 356977
4 FORM OF SUBORDINATED INDENTURE d361172dex414.htm EX-4.14 349450
5 OPINION OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C. d361172dex51.htm EX-5.1 40479
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d361172dex231.htm EX-23.1 2002
7 GRAPHIC g361172cov2logo.jpg GRAPHIC 20631
8 GRAPHIC g361172g32s94.jpg GRAPHIC 2432
  Complete submission text file 0001193125-12-255656.txt   1210303
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-181813 | Film No.: 12881076
SIC: 2836 Biological Products, (No Diagnostic Substances)